Anne Landsem
Bodo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Impact of Preanalytical Storage Time and Air Exposure on ROTEM and Coagulation Sample Stability.
Journal: Advances in hematology
Published: April 23, 2025
Complement C3b contributes to Escherichia coli-induced platelet aggregation in human whole blood.
Journal: Frontiers in immunology
Published: August 16, 2022
Dental and Periodontal Health in Acute Intermittent Porphyria.
Journal: Life (Basel, Switzerland)
Published: June 27, 2022
Venous Air Embolism Activates Complement C3 Without Corresponding C5 Activation and Trigger Thromboinflammation in Pigs.
Journal: Frontiers in immunology
Published: December 20, 2021
A Conformational Change of Complement C5 Is Required for Thrombin-Mediated Cleavage, Revealed by a Novel Ex Vivo Human Whole Blood Model Preserving Full Thrombin Activity.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 31, 2020
Cholesterol Crystals Induce Coagulation Activation through Complement-Dependent Expression of Monocytic Tissue Factor.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 03, 2019
Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14.
Journal: Molecular immunology
Published: November 27, 2018
Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4.
Journal: Clinical and experimental immunology
Published: November 09, 2018
Lifestyle factors including diet and biochemical biomarkers in acute intermittent porphyria: Results from a case-control study in northern Norway.
Journal: Molecular genetics and metabolism
Published: August 29, 2018
Systemic inflammation in acute intermittent porphyria: a case-control study.
Journal: Clinical and experimental immunology
Published: November 02, 2016
Combined Inhibition of Complement and CD14 Attenuates Bacteria-Induced Inflammation in Human Whole Blood More Efficiently Than Antagonizing the Toll-like Receptor 4-MD2 Complex.
Journal: The Journal of infectious diseases
Published: January 24, 2016
C1-inhibitor efficiently delays clot development in normal human whole blood and inhibits Escherichia coli-induced coagulation measured by thromboelastometry.
Journal: Thrombosis research
Published: October 22, 2015
Last Updated: 09/26/2026